Compliance rates and outcomes associated with a restrictive transfusion policy in gynecologic oncology patients. (отвара нови прозор)

Boone JD, Kim KH, Marques M, Straughn JM.

Извор‎: Gynecol Oncol 2014;132(1):227-30.

Индекс‎: PubMed 24512847

DOI‎: 10.1016/j.ygyno.2013.10.019

https://www.ncbi.nlm.nih.gov/pubmed/24512847 (отвара нови прозор)

Liberal or restrictive transfusion in high-risk patients after hip surgery. (отвара нови прозор)

Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, Nemo G, Dragert K, Beaupre L, Hildebrand K, Macaulay W, Lewis C, Cook DR, Dobbin G, Zakriya KJ, Apple FS, Horney RA, Magaziner J; FOCUS Investigators.

Извор‎: N Engl J Med 2011;365(26):2453-62.

Индекс‎: PubMed 22168590

DOI‎: 10.1056/NEJMoa1012452

https://www.ncbi.nlm.nih.gov/pubmed/22168590 (отвара нови прозор)

Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. (отвара нови прозор)

Chojnowski K, Janus A, Bliźniewska K, Robak M, Treliński J.

Извор‎: Transfusion 2016;56(10):2438-42.

Индекс‎: PubMed 27385671

DOI‎: 10.1111/trf.13703

https://www.ncbi.nlm.nih.gov/pubmed/27385671 (отвара нови прозор)

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (отвара нови прозор)

Ford PA, Grant SJ, Mick R, Keck G.

Извор‎: J Clin Oncol 2015;33(15):1674-9.

Индекс‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085 (отвара нови прозор)

Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. (отвара нови прозор)

Friedmann AM, Sengul H, Lehmann H, Schwartz C, Goodman S.

Извор‎: Transfus Med Rev 2002;16(1):34-45.

Индекс‎: PubMed 11788928

https://www.ncbi.nlm.nih.gov/pubmed/11788928 (отвара нови прозор)

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. (отвара нови прозор)

Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E; Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.

Извор‎: N Engl J Med 1999;340(6):409-17.

Индекс‎: PubMed 9971864

DOI‎: 10.1056/NEJM199902113400601

https://www.ncbi.nlm.nih.gov/pubmed/9971864 (отвара нови прозор)

Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit? (отвара нови прозор)

Leal-Noval SR, Muñoz-Gómez M, Jiménez-Sánchez M, Cayuela A, Leal-Romero M, Puppo-Moreno A, Enamorado J, Arellano-Orden V.

Извор‎: Intensive Care Med 2013;39(3):445-53.

Индекс‎: PubMed 23184038

DOI‎: 10.1007/s00134-012-2757-z

https://www.ncbi.nlm.nih.gov/pubmed/23184038 (отвара нови прозор)

How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. (отвара нови прозор)

Prescott LS, Taylor JS, Lopez-Olivo MA, Munsell MF, VonVille HM, Lairson DR, Bodurka DC.

Извор‎: Cancer Treat Rev 2016;46:1-8.

Индекс‎: PubMed 27046422

DOI‎: 10.1016/j.ctrv.2016.03.010

https://www.ncbi.nlm.nih.gov/pubmed/27046422 (отвара нови прозор)

Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. (отвара нови прозор)

Roubinian NH, Escobar GJ, Liu V, Swain BE, Gardner MN, Kipnis P, Triulzi DJ, Gottschall JL, Wu Y, Carson JL, Kleinman SH, Murphy EL; NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III).

Извор‎: Transfusion 2014;54(10 Pt 2):2678-86.

Индекс‎: PubMed 25135770

DOI‎: 10.1111/trf.12825

https://www.ncbi.nlm.nih.gov/pubmed/25135770 (отвара нови прозор)

Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open label, phase III, noninferiority trial. (отвара нови прозор)

Tay J, Allan DS, Chatelain E, Coyle D, Elemary M, Fulford A, Petrcich W, Ramsay T, Walker I, Xenocostas A, Tinmouth A, Fergusson D

Извор‎: J Clin Oncol 2020;38(13):1463-73.

Индекс‎: PubMed 32083994

DOI‎: 10.1200/JCO.19.01836

https://www.ncbi.nlm.nih.gov/pubmed/32083994 (отвара нови прозор)

Transfusion indications for patients with cancer. (отвара нови прозор)

Watkins T, Surowiecka MK, McCullough J.

Извор‎: Cancer Control 2015;22(1):38-46.

Индекс‎: PubMed 25504277

https://www.ncbi.nlm.nih.gov/pubmed/25504277 (отвара нови прозор)

Restrictive blood transfusion protocol in malignant upper gastrointestinal and pancreatic resections patients reduces blood transfusions with no increase in patient morbidity. (отвара нови прозор)

Wehry J, Agle S, Philips P, Cannon R, Scoggins CR, Puffer L, McMasters KM, Martin RC.

Извор‎: Am J Surg 2015;210(6):1197-204.

Индекс‎: PubMed 26602534

DOI‎: 10.1016/j.amjsurg.2015.08.013

https://www.ncbi.nlm.nih.gov/pubmed/26602534 (отвара нови прозор)